Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C173039> ?p ?o ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NCIT_C173039 IAO_0000115 "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with copanlisib in patients with tumors, excluding indolent non-Hodgkin lymphomas, diffuse large B cell lymphomas and HER2-positive breast cancers, that have PTEN gene mutations and are PTEN negative by immunohistochemical analysis." @default.
- NCIT_C173039 NCIT_NHC0 "C173039" @default.
- NCIT_C173039 NCIT_P106 "Intellectual Product" @default.
- NCIT_C173039 NCIT_P108 "MATCH Arm EAY131-Z1G" @default.
- NCIT_C173039 NCIT_P208 "CL1406840" @default.
- NCIT_C173039 NCIT_P322 "CTDC" @default.
- NCIT_C173039 normalizedInformationContent "100" @default.
- NCIT_C173039 referenceCount "1" @default.
- NCIT_C173039 hasExactSynonym "EAY131-Z1G" @default.
- NCIT_C173039 hasExactSynonym "MATCH Arm EAY131-Z1G" @default.
- NCIT_C173039 hasExactSynonym "Z1G" @default.
- NCIT_C173039 inSubset NCIT_C173073 @default.
- NCIT_C173039 type Class @default.
- NCIT_C173039 isDefinedBy ncit.owl @default.
- NCIT_C173039 label "MATCH Arm EAY131-Z1G" @default.
- NCIT_C173039 subClassOf NCIT_C171181 @default.
- NCIT_C173039 subClassOf NCIT_C172991 @default.
- NCIT_C173039 subClassOf NCIT_C173039 @default.
- NCIT_C173039 subClassOf NCIT_C19498 @default.
- NCIT_C173039 subClassOf NCIT_C20181 @default.
- NCIT_C173039 subClassOf NCIT_C25198 @default.
- NCIT_C173039 subClassOf NCIT_C25364 @default.
- NCIT_C173039 subClassOf NCIT_C70663 @default.
- NCIT_C173039 subClassOf NCIT_C97331 @default.